Non-Reliance of Financial Report (Form 8-K)

Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

(a) On May 30, 2026, the management of Redox International Group, Corp. (formerly Intorio, Corp.) (the "Company"), together with the Board of Directors of the Company, concluded that the Company's previously issued unaudited interim financial statements for the quarterly periods ended August 31, 2024 and November 30, 2024 (collectively, the "Affected Periods"), as included in the Company's Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on October 31, 2024 and February 19, 2025, respectively, should no longer be relied upon. Accordingly, any previously issued press releases, investor presentations, and other communications describing the Company's financial results for the Affected Periods should likewise no longer be relied upon.

The determination to restate the financial statements for the Affected Periods arose from the Company's conclusion that those financial statements did not reflect the issuance of 50,850,000 shares of the Company's common stock on June 5, 2024 to certain founders, advisors, and consultants under certain Founder Agreements and Advisory Agreements, or the related stock-based compensation required to be recognized under ASC 718, Compensation-Stock Compensation. As originally filed, the financial statements for each of the quarters ended August 31, 2024 and November 30, 2024 reported 3,235,000 shares of common stock issued and outstanding and stated that the Company had not issued any stock-based payments, neither of which reflected the June 5, 2024 issuances. The Company has determined that the compensation cost associated with these share issuances must be measured at the grant-date fair value of the awards and recognized over the applicable requisite service period in accordance with ASC 718.

As a result of correcting these errors, the Company expects the restatement to affect, for one or more of the Affected Periods, the following: shares of common stock issued and outstanding; weighted-average shares outstanding; stock-based compensation expense; general and administrative expense; net loss; net loss per share; common stock; additional paid-in capital; and deferred (unearned) stock-based compensation reported within stockholders' equity, together with the related subtotals and totals. The restatement is non-cash in nature and is not expected to affect the Company's previously reported cash, cash equivalents, or total cash flows. The Company is in the process of finalizing the amount of the adjustments, which remains subject to the completion of the restatement process and the procedures of its independent registered public accounting firm.

The Company intends to restate the financial statements for the Affected Periods by filing amended Quarterly Reports on Form 10-Q/A with the SEC as promptly as practicable. Until the amended reports are filed, investors and others should not rely on the financial statements and related disclosures for the Affected Periods.

The Company does not have a separate audit committee. The Company's Board of Directors has discussed the matters disclosed in this Item 4.02(a) with the Company's independent registered public accounting firm, Michael Gillespie & Associates, PLLC.